Healthcare provider profile · identity verified

Timothy A Theobald, DO

Family Practice · SANFORD, ME · NPI 1104895648

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	500	157
Lisinopril	Lisinopril	402	124
Simvastatin	Simvastatin	265	75
Amlodipine Besylate	Amlodipine Besylate	259	84
Levothyroxine Sodium	Levothyroxine Sodium	241	67
Omeprazole	Omeprazole	205	61
Losartan Potassium	Losartan Potassium	187	59
Hydrochlorothiazide	Hydrochlorothiazide	181	57
Metformin Hcl	Metformin Hcl	180	55
Tamsulosin Hcl	Tamsulosin Hcl	141	42
Alendronate Sodium	Alendronate Sodium	124	34
Jardiance	Empagliflozin	123	33
Metoprolol Succinate	Metoprolol Succinate	106	29
Albuterol Sulfate Hfa	Albuterol Sulfate	105	36
Allopurinol	Allopurinol	98	29
Atenolol	Atenolol	89	26
Gabapentin	Gabapentin	88	28
Eliquis	Apixaban	77	23
Rosuvastatin Calcium	Rosuvastatin Calcium	76	27
Sertraline Hcl	Sertraline Hcl	74	23
Furosemide	Furosemide	73	25
Finasteride	Finasteride	70	21
Pantoprazole Sodium	Pantoprazole Sodium	70	18
Duloxetine Hcl	Duloxetine Hcl	68	20
Lovastatin	Lovastatin	60	16
Pioglitazone Hcl	Pioglitazone Hcl	60	20
Tramadol Hcl	Tramadol Hcl	59	14
Fluticasone Propionate	Fluticasone Propionate	57	21
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	17
Breo Ellipta	Fluticasone/Vilanterol	56	suppressed
Ozempic	Semaglutide	56	13
Glipizide Er	Glipizide	53	15
Lorazepam	Lorazepam	53	11
Metoprolol Tartrate	Metoprolol Tartrate	50	16
Metformin Hcl Er	Metformin Hcl	49	16
Glipizide	Glipizide	47	19
Trazodone Hcl	Trazodone Hcl	47	17
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	17
Triamcinolone Acetonide	Triamcinolone Acetonide	40	21
Venlafaxine Hcl Er	Venlafaxine Hcl	40	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	11
Trulicity	Dulaglutide	38	suppressed
Prednisone	Prednisone	37	33
Clonazepam	Clonazepam	36	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	36	suppressed
Bupropion Xl	Bupropion Hcl	35	11
Famotidine	Famotidine	34	12
Mirtazapine	Mirtazapine	34	suppressed
Diclofenac Sodium	Diclofenac Sodium	33	suppressed
Carvedilol	Carvedilol	29	13
Warfarin Sodium	Warfarin Sodium	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Irbesartan	Irbesartan	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	13
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	22	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Incruse Ellipta	Umeclidinium Bromide	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Ezetimibe	Ezetimibe	19	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	18	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Montelukast Sodium	Montelukast Sodium	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Potassium Chloride	Potassium Chloride	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Temazepam	Temazepam	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Mupirocin	Mupirocin	11	suppressed
Myrbetriq	Mirabegron	11	suppressed
Oxycodone Hcl	Oxycodone Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error